HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


EU Working Group: Cosmetics Should Be 'Free From' Denigrating Ingredient Claims

This article was originally published in The Rose Sheet

Executive Summary

"Paraben-free" claims should not be allowed on cosmetic products because they denigrate the entire ingredient group, including safe options authorized for EU use, a European Commission working group asserts in recently published guidance. It remains to be seen if and how national regulatory authorities implement the guidance and how brands react that have made such claims a core component of their ethos.

You may also be interested in...

European Guidelines Now In Effect For ‘Free From,’ ‘Hypoallergenic’ Cosmetic Claims

According to Cosmetics Europe, at least “several” EU Member States are expected to be monitoring the marketplace for compliance with guidance developed by a European Commission working group, key aspects of which – concerning “free from” and “hypoallergenic” claims – went into effect 1 July.

‘Hypoallergenic’ Class Actions Bubbling Up: The New ‘Natural’ Scourge?

There are similarities between trending “hypoallergenic” class actions and “natural” litigation that for years has been the bane of many leading brands and a cash cow for plaintiffs.

Target, Whole Foods Have Irritated Reactions To ‘Hypoallergenic’ Product Suits

The outcomes of proposed class actions against Target Corporation and Whole Foods Market will provide bright signals as to whether plaintiffs have traction in the courts to bring false-advertising suits against “hypoallergenic” cosmetic marketers. The retailers’ motions to dismiss are pending currently.

Related Content





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts